The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR

Human Immunology

Volumn 64, Issue 9, 2003, Pages 896-901

  Peng, Jun ^a   Liu, Chuanfang ^b   Zhu, Kunli ^b   Zhu, Yuanyuan ^b   Yu, Yuan ^b   Li, Jie ^b   Hou, Ming ^b   Chen, Xueliang ^b   Xu, Conggao ^b   Zhang, Maohong ^b  

^a SHANDONG UNIVERSITY   (China)

^b NONE

Author keywords

HLA; Polymorphism; Severe aplastic anemia; Tumor necrosis factor

Indexed keywords

HLA DR ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; TUMOR NECROSIS FACTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

EID: 10744230199     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00141-1     Document Type: Article

References (38)

1. Nakao S: Immune mechanisms of aplastic anemia. Int J Hematol 66:127, 1997.
2. Zeng W, Nakao S, Takamatsu H, Yachie A, Takami A, Kondo Y, Sugimori N, Yamazaki H, Miura Y, Shiobara S, Matsuda T: Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T cell response in cyclosporine-dependent aplastic anemia. Blood 93:3008, 1999.
3. Young NS, Maciejewski J: The pathophysiology of acquired aplastic anaemia. N Engl J Med 336:1365, 1997.
4. Shao W, Tian D, Liu C, Sun X, Zhang X: Aplastic anemia is associated with HLA-DRB1*1501 in northern Han Chinese. Int J Hematol 71:350, 2000.
5. Ilhan O, Beksac M, Koc H, Akan H, Keskin A, Arslan O, Gurman G, Ozcan M, Konuk N, Uysal A: HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy. Blood 86:2055, 1995.
6. Nimer SD, Ireland P, Meshkinpour A, Frane M: An increased HLA-DR2 frequency is seen in aplastic anemia patients. Blood 84:923, 1994.
7. Kapustin SI, Popova TI, Lyschov AA, Togo AV, Abdulkadyrov KM, Blinov MN: HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype. Pathol Oncol Res 3:106, 1997.
8. Nakao S, Takamatsu H, Chuhjo T, Ueda M, Shiobara S, Matsuda T, Kaneshige T, Mizoguchi H: Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood 84:4257, 1994.
9. Chiewsilp P, Sujirachato K, Mongkolsuk T, Junpong S, Jootar S, Hathirat P: Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais. J Med Assoc Thai 83(Suppl 1):S130, 2000.
10. Kapustin SI, Popova TI, Lyshchov AA, Imyanitov EN, Blinov MN, Abdulkadyrov KM: HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia. Ann Hematol 80:66, 2001.
11. Schultz JC, Shahidi NT: Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol 45:32, 1994.
12. Viale M, Merli A, Bacigalupo A: Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood 78:1268, 1991.
13. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS: Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 91:245, 1995.
14. Maciejewski JP, Selleri C, Anderson S, Young NS: Fas antigen expression on CD34+ human morrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995.
15. Allen RD: Polymorphism of the human TNF-alpha promoter-random variation or functional diversity? Mol Immunol 36:1017, 1999.
16. Abraham LJ, Kroeger KM: Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66:562, 1999.
17. Wilson AG, Gordon C, di Giovine FS, van der Putte LB, Emery P, Duff GW: A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24:191, 1994.
18. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW: TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129, 2000.
19. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Neurp J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224, 1993.
20. Bernal W, Moloney M, Underhill J, Donaldson PT: Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 30:237, 1999.
21. Jones DEJ, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, Day CP: Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis. J Hepatol 30:232, 1999.
22. de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA: Celiac disease and TNF promoter polymorphisms. Hum Immunol 61:513, 2000.
23. Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT: Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 30:851, 1999.
24. Heward J, Gough CL: Genetic susceptibility to the development of autoimmune disease. Clin Sci 93:479, 1997.
25. Camitta B, O'Reilly RJ, Sensenbrenner L, Rappeport J, Champlin R, Doney K, August C, Hoffmann RG, Kirkpatrick D, Stuart R, Santos G, Parkman R, Gale RP, Storb R, Nathan D: Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood 62:883, 1983.
26. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225, 1992.
27. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557, 1993.
28. McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D: TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 26:2113, 1996.
29. Svejgaard A, Ryder LP: HLA and disease associations: detecting the strongest association. Tissue Antigens 43: 18, 1994.
30. Guo SW, Thompson EA: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361, 1992.
31. Cox A, Gonzalez AM, Wilson AG, Wilson RM, Ward JD, Artlett CM, Welsh K, Duff GW: Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 37:500, 1994.
32. Huizinga TWJ, Westendorp RGJ, Bollen ELEM, Keijsers V, Brinkman BMN, Langermans JAM, Breedveld FC, Garcia-Gonzalez A, van Oosten BW, Polman CH, Pena AS: TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72:149, 1997.
33. Demeter J, Messer G, Schrezenmeier H: Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia. Ann Hematol 81:566, 2002.
34. Chen CJ, Yen JH, Tsai WC, Wu CS, Chiang W, Tsai JJ, Liu HW: The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett 55:1, 1997.
35. Fong KY, Howe HS, Tin SK, Boey ML, Feng PH: Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore 25:90, 1996.
36. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K: Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 51:605, 1998.
37. Kamradt T, Mitchison NA: Tolerance and autoimmunity. N Engl J Med 344:655, 2001.
38. Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D: A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73, 1994.